Adgero

Adgero

Adgero

Adgero Biopharmaceuticals is leveraging its late stage photodynamic therapy (PDT) platform for the treatment of serious oncology indications.
Suggest edits
Founded
2012
Raised
$2M
Follow us
Companies in the same industry
Alexa global traffic share